192 related articles for article (PubMed ID: 38773611)
21. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis.
Mamyrova G; Kishi T; Targoff IN; Ehrlich A; Curiel RV; Rider LG;
Rheumatology (Oxford); 2018 Nov; 57(11):1956-1963. PubMed ID: 30016492
[TBL] [Abstract][Full Text] [Related]
22. A case of anti-SAE1/2 antibody-positive dermatomyositis with extensive panniculitis: A possible cutaneous manifestation of treatment resistance.
Fujisaki M; Kasamatsu H; Nishimura K; Yoshida Y; Muneishi Y; Yamaguchi T; Nishino I; Konishi R; Ichimura Y; Okiyama N; Oyama N; Hasegawa M
J Dermatol; 2024 Feb; 51(2):301-306. PubMed ID: 37830399
[TBL] [Abstract][Full Text] [Related]
23. Juvenile dermatomyositis: a case of delayed recognition with unusual complication of nephrocalcinosis.
Sangeetha G; Dhanabal D; Mouttou Prebagarane S; Janarthanan M
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33795282
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in dermatomyositis-specific autoantibodies.
Fujimoto M; Watanabe R; Ishitsuka Y; Okiyama N
Curr Opin Rheumatol; 2016 Nov; 28(6):636-44. PubMed ID: 27533321
[TBL] [Abstract][Full Text] [Related]
25. Juvenile dermatomyositis in Thai children: Retrospective review of 30 cases from a tertiary care center.
Nitiyarom R; Charuvanij S; Likasitwattanakul S; Thanoophunchai C; Wisuthsarewong W
Indian J Dermatol Venereol Leprol; 2022; 88(2):162-170. PubMed ID: 34491668
[TBL] [Abstract][Full Text] [Related]
26. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis.
Gunawardena H; Wedderburn LR; North J; Betteridge Z; Dunphy J; Chinoy H; Davidson JE; Cooper RG; McHugh NJ;
Rheumatology (Oxford); 2008 Mar; 47(3):324-8. PubMed ID: 18238791
[TBL] [Abstract][Full Text] [Related]
27. Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review.
Yeung TW; Cheong KN; Lau YL; Tse KN
Pediatr Rheumatol Online J; 2021 Jun; 19(1):103. PubMed ID: 34193210
[TBL] [Abstract][Full Text] [Related]
28. Antibodies to small ubiquitin-like modifier activating enzyme are associated with a diagnosis of dermatomyositis: results from an unselected cohort.
Peterson LK; Jaskowski TD; La'ulu SL; Tebo AE
Immunol Res; 2018 Jun; 66(3):431-436. PubMed ID: 29845587
[TBL] [Abstract][Full Text] [Related]
29. Lung infection or inflammation-a puzzling case of MDA-5 associated juvenile dermatomyositis.
Vuppala A; Sondhi M; Umer S
Pediatr Rheumatol Online J; 2023 Dec; 21(1):147. PubMed ID: 38124190
[TBL] [Abstract][Full Text] [Related]
30. Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis.
Lanis A; Volochayev R; Kleiner DE; Vittal A; Heller T; Rider LG; Shenoi S
Pediatr Rheumatol Online J; 2022 Apr; 20(1):30. PubMed ID: 35443665
[TBL] [Abstract][Full Text] [Related]
31. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
32. Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review.
Nishi K; Ogura M; Tamai N; Gima M; Ide K; Koinuma G; Kamei K; Ito S
Pediatr Rheumatol Online J; 2022 Aug; 20(1):60. PubMed ID: 35927666
[TBL] [Abstract][Full Text] [Related]
33. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.
Shah M; Mamyrova G; Targoff IN; Huber AM; Malley JD; Rice MM; Miller FW; Rider LG;
Medicine (Baltimore); 2013 Jan; 92(1):25-41. PubMed ID: 23263716
[TBL] [Abstract][Full Text] [Related]
34. [Juvenile dermatomyositis].
Dressler F; Huppertz HI
Z Rheumatol; 2006 Nov; 65(7):587-90, 592-4. PubMed ID: 17051362
[TBL] [Abstract][Full Text] [Related]
35. A fatal presentation of dermatomyositis with facial swelling.
Dwivedi N; Michael C; Lew DB; Arnold S; Igarashi M; Bertorini T; Thompson JW; Myers LK; Brown ML
Int J Pediatr Otorhinolaryngol; 2012 May; 76(5):745-9. PubMed ID: 22376996
[TBL] [Abstract][Full Text] [Related]
36. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
Kim H; Gunter-Rahman F; McGrath JA; Lee E; de Jesus AA; Targoff IN; Huang Y; O'Hanlon TP; Tsai WL; Gadina M; Miller FW; Goldbach-Mansky R; Rider LG
Arthritis Res Ther; 2020 Apr; 22(1):69. PubMed ID: 32252809
[TBL] [Abstract][Full Text] [Related]
37. A Case of Dermatomyositis with Coexistence of Positive Anti-MDA5 Antibodies and Anti-SSA/RO52 Antibodies, Combined with Necrotic Skin Ulcers.
Sun T; Hu ZH; He JS; Chen YC; Gao YX
Int Med Case Rep J; 2024; 17():9-15. PubMed ID: 38205150
[TBL] [Abstract][Full Text] [Related]
38. Evolution of Seronegative Inflammatory Myositis to Dermatomyositis With Characteristic Cutaneous Features: A Case Report.
Jevtic D; Dharmah U; Bahar M
J Investig Med High Impact Case Rep; 2023; 11():23247096231217829. PubMed ID: 38097369
[TBL] [Abstract][Full Text] [Related]
39. Clinical Characteristics and Course of Patients with Juvenile Dermatomyositis - Case Series.
Rajarathinam I; Raghuram J; Rao AP
Neurol India; 2022; 70(1):300-303. PubMed ID: 35263900
[TBL] [Abstract][Full Text] [Related]
40. Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy.
Ueda-Hayakawa I; Hamaguchi Y; Okiyama N; Motegi S; Yamaoka T; Miyake S; Higashi A; Okamoto H; Takehara K; Fujimoto M
Br J Dermatol; 2019 Apr; 180(4):881-887. PubMed ID: 30120913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
